Lipoprotein(a) and coronary thrombosis and restenosis after stent placement (original) (raw)
Plasma Lipoprotein(a) Is Not a Predictor for Restenosis After Elective High-Pressure Coronary Stenting
Valeria Ferrero
Circulation, 1998
View PDFchevron_right
High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease
Masaaki Miyata
American Heart Journal, 1996
View PDFchevron_right
Lipoprotein (a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease
Mike Gibney
1994
View PDFchevron_right
Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosis
hamid aghaee
Archives of Medical Science
View PDFchevron_right
The influence of plasma lipoprotein (a) on angiographic restenosis and coronary events in patients undergoing planned coronary balloon angioplasty Ancillary analysis of the Fluvastatin Angioplasty Restenosis (FLARE) trial
guy lloyd
Atherosclerosis, 2001
View PDFchevron_right
High Level of Lipoprotein (a) is a Strong Predictor for Progression of Coronary Artery Disease
Hiroyuki Daida
Journal of Atherosclerosis and Thrombosis, 1998
View PDFchevron_right
Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients
Graziella Bonetti
Journal of Diabetes and its Complications, 2003
View PDFchevron_right
Is In-Stent Restenosis After a Successful Coronary Stent Implantation Due to Stable Angina Associated With TG/HDL-C Ratio?
Ender Örnek
Angiology, 2017
View PDFchevron_right
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents
Madhav Sharma
The American Journal of Cardiology, 2020
View PDFchevron_right
Lower Level of Low-density Lipoprotein Cholesterol by Statin Prevents Progression of Coronary Restenosis after Successful Stenting in Acute Myocardial Infarction
Minako Yamaoka-Tojo
Internal Medicine, 2006
View PDFchevron_right
Persistent High Levels of Plasma Oxidized Low-Density Lipoprotein After Acute Myocardial Infarction Predict Stent Restenosis
Shoichi Ehara
Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
View PDFchevron_right
Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty
D. Prisco
Atherosclerosis, 2001
View PDFchevron_right
Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease
Christina Tsitsimpikou
Experimental and Therapeutic Medicine
View PDFchevron_right
Original ArticleOrigi al Article Increased Serum Levels of Lipoprotein(a) Correlated with the Severity of Coronary Artery Disease in Patients Submitted to Angiography
Maria das Graças Carvalho
2016
View PDFchevron_right
Predictive Factors of Restenosis After Coronary Stent Placement
Shpend Elezi
Journal of The American College of Cardiology, 1997
View PDFchevron_right
Lipoprotein(a) Level Does Not Predict Restenosis After Percutaneous Transluminal Coronary Angioplasty
Poonam Alaigh
Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
View PDFchevron_right
The relationship between lipoprotein(a) and coronary artery disease, as well as its variable nature following myocardial infarction
Ender Örnek
Clinical & Investigative Medicine, 2011
View PDFchevron_right
Lipoprotein(a) Is Related to the Extent of Lesions in the Coronary Vasculature and to Unstable Coronary Syndromes
NAOUM KARAMINAS
Clinical Cardiology, 2000
View PDFchevron_right
Lipoprotein(a) in cardiovascular diseases
Marco Vacante
BioMed research international, 2013
View PDFchevron_right
Impact of Lipoprotein(a) as Residual Risk on Long-Term Outcomes in Patients After Percutaneous Coronary Intervention
Hiroyuki Daida
The American Journal of Cardiology, 2015
View PDFchevron_right
Correlation Lipoprotein A Level with Complexity of Coronary Lesion in Coronary Heart Disease Patient at Rsup Dr. Sardjito Yogyakarta
Nahar Taufiq
Bangladesh Journal of Medical Science, 2016
View PDFchevron_right
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients [published erratum appears in Arteriosclerosis 1990 Nov-Dec;10(6):1147]
M. Dietel
Arteriosclerosis, Thrombosis, and Vascular Biology, 1989
View PDFchevron_right
Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery
Wendy Taddei-Peters
Atherosclerosis, 1998
View PDFchevron_right
Risk factors associated with intra‑stent restenosis after percutaneous coronary intervention
Anca Alexandrescu
Experimental and Therapeutic Medicine, 2021
View PDFchevron_right
Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis
Samet YILMAZ
Biomarkers in Medicine, 2016
View PDFchevron_right
Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease
Eduardo Gómez Aguilar
Atherosclerosis, 2018
View PDFchevron_right
Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease
Michael Domanski
Journal of the American College of Cardiology, 2014
View PDFchevron_right
Postprandial levels of lipoprotein(a) in subjects with or without coronary artery disease
Adriana Santos
International Journal of Cardiology, 1996
View PDFchevron_right
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d’Athérosclérose (NSFA)
Eduardo Angles-cano
Archives of Cardiovascular Diseases, 2021
View PDFchevron_right
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
Alberico Catapano
European Heart Journal, 2022
View PDFchevron_right
High Lipoprotein(a) Levels and Risk of Aortic Valve Stenosis Related Clinical Events: A Systematic Review
Pablo Oberti
Revista Argentina de Cardiologia
View PDFchevron_right
Is Lipoprotein (a) a Risk Factor for Coronary Artery Ectasia?
Baha Alshraideh
Cardiology Research, 2020
View PDFchevron_right
Lipoprotein (a) is increased in acute coronary syndromes (unstable angina pectoris and myocardial infarction), but it is not predictive of the severity of coronary lesions
Paolo Spallarossa
Clinical Cardiology, 1995
View PDFchevron_right